Measurement of glycated hemoglobin (HbA1c) has been the traditional method for
assessing glycemic control. However, it does not reflect intra-and interday glycemic …

Continuous glucose monitoring (CGM) is an increasingly adopted technology for insulin-
requiring patients that provides insights into glycemic fluctuations. CGM can assist patients …

Background Adults with type 1 diabetes who are treated with multiple daily injections of
insulin plus intermittently scanned continuous glucose monitoring (isCGM) can have …

ISPAD Clinical Practice Consensus Guidelines 2018: Diabetes technologies Page 1 ISPAD
CLINICAL PRACTICE CONSENSUS GUIDELINES ISPAD Clinical Practice Consensus …

Background: Patients with diabetes mellitus need information about the effectiveness of
innovations in insulin delivery and glucose monitoring. Purpose: To review how intensive …

Aims/hypothesis The aim of this multicentre, randomised, controlled crossover study was to
determine the efficacy of adding continuous glucose monitoring (CGM) to insulin pump …

Context Randomized controlled trials evaluating real-time continuous glucose monitoring
(RT-CGM) patients with type 1 diabetes (T1D) show improved glycemic control, but limited …

Research on and commercial development of the artificial pancreas (AP) continue to
progress rapidly, and the AP promises to become a part of clinical care. In this report …

Background Self‐monitoring of blood glucose is essential to optimise glycaemic control in
type 1 diabetes mellitus. Continuous glucose monitoring (CGM) systems measure interstitial …

Aims Self-monitoring of blood glucose (SMBG) represented a major breakthrough in the
treatment of type 1 diabetes. The aim of the present meta-analysis is to assess the effect of …